Christopher B. Prentiss
Chief Financial OfficerMr. Christopher B. Prentiss, also known as Chris, MBA, serves as Chief Financial Officer of MannKind Corporation since April 22, 2024. He had been Chief Financial Officer at Adamas Pharmaceuticals, Inc. since November 1, 2019 until November 24, 2021. He served as the Chief Financial Officer for ADARx Pharmaceuticals, Inc. from September 2022 to March 2024. He served as Chief Accounting Officer at Adamas Pharmaceuticals, Inc. since September 15, 2017 until 2019. Mr. Prentiss served as Senior Vice President of Finance at Adamas Pharmaceuticals, Inc. since September 15, 2017 until November 1, 2019. He served as Vice President of Finance and Controller at Adamas Pharmaceuticals, Inc. since joining it in April 2015. Mr. Prentiss served as the Vice President of Finance and Controller at InterMune, Inc. from June 2013 to March 2015, where he was responsible for the management of the accounting function. Mr. Prentiss served as Senior Director, Controller at Dynavax Technologies Corporation from May 2012 to June 2013, where he was responsible for the accounting and tax functions. From June 2005 to May 2012, Mr. Prentiss was at MannKind Corporation where he served in a variety of finance roles, as Senior Director, Controller. Mr. Prentiss was a Senior Manager at KPMG LLP in the assurance practice. He began his career in the assurance practice at KPMG LLP. A licensed CPA (inactive) in California. Mr. Prentiss received a Bachelor of Science degree in Accounting from Loyola Marymount University and a Masters of Business Administration from Indiana University. Mr. Prentiss is a CPA licensed in California.
Positions
- Company NameMannKind CorporationStock CodeMNKDPositionChief Financial OfficerColleagues
- MEMichael E. CastagnaCEO & Director
- JSJames S. ShannonIndependent Chairman
- DBDavid B. ThomsonExecutive VP, General Counsel & Secretary
- SAStuart A. TrossChief People & Workplace Officer
- DMDominic MarascoPresident of Endocrine Business Unit
- KKKent KresaChairman Emeritus
- RJRonald J. ConsiglioIndependent Director
- ACAnthony C. HooperIndependent Director
